Please assess the completion status of the following clinical trial:

Trial Title: Effects of Hormone Stimulation on Brain Scans for Cushing s Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: SINGLE
- Phase: EARLY_PHASE1
- Number of Arms: None

Eligibility Criteria:
* INCLUSION CRITERIA:~To be eligible for entry into the study, patients must meet all the following criteria:~1. Be 8 years of age or older and able to undergo PET-imaging without needing general anesthesia.~2. Able to provide informed consent (or guardian is able to provide consent in case of minor).~3. Clinical diagnosis of CD based on medical records.~4. Medically able to undergo resection of pituitary adenoma and planning to undergo surgical resection of adenoma within 12 weeks of PET-imaging.~5. Normal liver enzymes: tests should be completed within 14 days before injection of the radiopharmaceutical; SGOT, SGPT less than or equal to 5 times ULN; bilirubin less than or equal to 2 times ULN.~EXCLUSION CRITERIA:~Candidates will be excluded if they meet any of the following criteria:~1. Pregnant or nursing women.~2. Contraindication to MR-scanning, including pacemakers or other implanted electrical devices, brain stimulators, some types of dental implants, aneurysm clips (metal clips on the wall of a large artery), metallic prostheses (including metal pins and rods, heart valves, and cochlear implants), permanent eyeliner, implanted delivery pump, or shrapnel fragments~3. Severe chronic renal insufficiency (glomerular filtration rate \< 30 mL/min/1.73 m(2)), hepatorenal syndrome or post-liver transplantation.~4. Elevated blood glucose level above 200 mg/dL on the day of the scan prior to (18)F-FDG administration.~5. Known intolerance to CRH.

- Gender: ALL
- Minimum Age: 8 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).